Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Knight Therapeutics Inc. T.GUD

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Knight Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products.
Price: $6.70 | Change: +$0.05 | %Change: +0.75%
Volume: 202,106 | Day High/Low: 6.82/6.67 | 52 Week High/Low: 10.00/4.81
View modes: 
5 stars

RE:Jason Donville comments on T.GUD

It isn't obvious where he'll use the cash. he is very creative and very to time this guy is a mistake (IMO). Like I've said since day 1 of this stock...I held Paladin as more
0 stars

M. Smedley commets on GUD

15-06-30 BUY Knight Therapeutics GUD-T Michael Smedley He is positive on a very long-term progress of them. In the short term, it has been hit by the more
0 stars

Jason Donville comments on T.GUD

Mr. Donville was on Market Call today and said he would not recommend the stock.  He thinks the company is holding too much cash and he thinks it could be years before Mr. Goodman can deploy it more
5 stars

Don't stop there...there's more news...

MONTREAL, June 26, 2015 /CNW Telbec/ - Extenway Solutions Inc. ("Extenway") (TSXV: EY) is pleased to announce the closing, as of June 26, 2015 (the "Closing Date"), of a secured equipment loan more
5 stars

Knight News After Hours  rate and reply
0 stars

Flower day "where's Waldo"

Remember...I was asking about the execs from Orphan.  One is back with Pro Bono. Also, Knight just struck a deal with Synery Strips, making that relationship stronger.  See the news release more
0 stars

RE:RE:Knight & Pro Bono Bio

Knight slowly doing what it can from pdp, prn , now Pro bono..If it could make a deal like this often with debt bearing interest of 10% -or higher plus the equity interest and commercialization more
3 stars

RE:Knight & Pro Bono Bio

Another astute move by GUD. Mr. Jonathan Ross Goodman reports CHIVALROUS KNIGHT DOES PRO BONO Knight Therapeutics Inc. has (1) extended a secured loan of $15-million (U.S.) to Pro Bono Bio more
0 stars

Knight & Pro Bono Bio

MONTREAL, QUEBEC--(Marketwired - June 26, 2015) - Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced today that it has ( more
0 stars

Pro Bono Bio deal

MONTREAL, QUEBEC, Jun 26, 2015 (Marketwired via COMTEX) -- Knight Therapeutics Inc. (GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced today that it has more
0 stars

holding $7

.  rate and reply
0 stars

RE:Why so quiet?

With the recent acquisitions of trx, there are still a lot of bargain in this sector like Pdp...Knight should start using their cash hoard as M&A activies are heating up, its seems that more
0 stars

Why so quiet?

Too quiet right now. Goodman!  Let's make some noise. Buy me something as an early Christmas gift...would ya?  rate and reply
0 stars

nobody =somebody

somebody purchased 385,000 shares Friday  rate and reply
0 stars

RE:I am looking

I don't think anyone is buying this thing... 1.  Goodman is about fifteen+ years from selling 2.  It's just a bag of money...with a few hints of what Knight might eventually look like. Knight more
0 stars

I am looking

For knight and merus to become one who will buy whom  rate and reply
0 stars

Did I forget to mention...

Did I forget to mention that I like it much better when this stock is north of $7.00 per share? : )  rate and reply
0 stars

RE:Globe's Dowty recommends buying Knight Therapeutics

At some point... And they have the cash.... They will make their first major acquisition. This would be a junior pharma with commercial sales and an attractive drug pipeline. The valuation could more
0 stars


Baystreetlover wrote: BaystreetBrian is actually correct. TD does not do electronic trading on Day 1 of an IPO. Only over the phone. Nice try though.......idiot.  OMG you signed in too your more
0 stars


I'm much happier when this stock is above $7 : )  rate and reply